The association between serum adiponectin and carotid intima media thickness in community based cohort in Korea: The ARIRANG study

Molecular and Cellular Toxicology

Volumn 7, Issue 1, 2011, Pages 33-38

  Ahn, Min Soo ^a   Koh, Sang Baek ^b   Kim, Jang Young ^b   Yoon, Jin Ha ^b   Sung, Joong Kyung ^b   Youn, Young Jin ^b   Yoo, Byung Su ^b   Lee, Seung Hwan ^b   Yoon, Junghan ^b   Eom, Aeyong ^c   Park, Jong Ku ^b   Choe, Kyung Hoon ^b  

^a Pusan National University Hospital   (South Korea)

^b Yonsei University Wonju   (South Korea)

^c Mokpo National University   (South Korea)

Author keywords

Adiponectin; Atherosclerosis; Carotid Artery

Indexed keywords

EID: 79960089610     PISSN: 1738642X     EISSN: 20928467     Source Type: Journal    
DOI: 10.1007/s13273-011-0005-1     Document Type: Article

References (34)

1. MacDougald, O. A. & Burant, C. F. The rapidly expanding family of adipokines. Cell Metab 6:159-161 (2007). (Pubitemid 47324145)
2. Cao, H. et al. Identification of a lipokine, a lipid hormone linking adipose tissue to systemic metabolism. Cell 134:933-944 (2008).
3. Kershaw, E. E. & Flier, J. S. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 89:2548-2556 (2004). (Pubitemid 38766330)
4. Eringa, E. C. et al. Regulation of vascular function and insulin sensitivity by adipose tissue: focus on perivascular adipose tissue. Microcirculation 14:389-402 (2007). (Pubitemid 47050030)
5. Ikeoka, D., Mader, J. K. & Pieber, T. R. Adipose tissue, inflammation and cardiovascular disease. Rev Assoc Med Bras 56:116-121 (2010).
6. Chatterjee, T. K. et al. Proinflammatory phenotype of perivascular adipocytes: influence of high-fat feeding. Circ Res 104:541-549 (2009).
7. Dallinga-Thie, G. M. & Dullaart, R. P. Do genomewide association scans provide additional information on the variation of plasma adiponectin concentrations? Atherosclerosis 208:328-329 (2010).
8. Stefan, N. & Stumvoll, M. Adiponectin-its role in metabolism and beyond. Horm Metab Res 34:469-474 (2002).
9. Nishida, M., Funahashi, T. & Shimomura, I. Pathophysiological significance of adiponectin. Med Mol Morphol 40:55-67 (2007). (Pubitemid 47305235)
10. Iglseder, B. et al. Plasma adiponectin levels and sonographic phenotypes of subclinical carotid artery atherosclerosis: data from the SAPHIR Study. Stroke 36: 2577-2582 (2005).
11. Kiris, I. et al. Inverse relationship between adiponectin levels and subclinical carotid atherosclerosis in patients undergoing coronary artery bypass grafting. Int Heart J 47:855-866 (2006).
12. Pischon, T. et al. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 291:1730-1737 (2004). (Pubitemid 38489895)
13. Lawlor, D. A., Davey Smith, G., Ebrahim, S., Thompson, C. & Sattar, N. Plasma adiponectin levels are associated with insulin resistance, but do not predict future risk of coronary heart disease in women. J Clin Endocrinol Metab 90:5677-5683 (2005). (Pubitemid 41415475)
14. Costacou, T. et al. The prospective association between adiponectin and coronary artery disease among individuals with type 1 diabetes. The Pittsburgh Epidemiology of Diabetes Complications Study. Diabetologia 48:41-48 (2005). (Pubitemid 40174655)
15. Zoccali, C. et al. Adiponectin, metabolic risk factors, and cardiovascular events among patients with endstage renal disease. J Am Soc Nephrol 13:134-141 (2002). (Pubitemid 34042020)
16. Karakas, M. et al. Leptin, adiponectin, their ratio and risk of Coronary Heart Disease: results from the MONICA/KORA Augsburg Study 1984-2002. Atherosclerosis209:220-225 (2010).
17. Yamauchi, T. et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7:941-946 (2001). (Pubitemid 32756432)
18. Ran, J. et al. Angiotensin II infusion decreases plasma adiponectin level via its type 1 receptor in rats: an implication for hypertension-related insulin resistance. Metabolism 55:478-488 (2006).
19. Chu, N. F. et al. Plasma insulin, leptin, and soluble TNF receptors levels in relation to obesity-related atherogenic and thrombogenic cardiovascular disease risk factors among men. Atherosclerosis 157:495-503 (2001).
20. Wannamethee, S. G. et al. Adipokines and risk of type 2 diabetes in older men. Diabetes Care 30:1200-1205 (2007). (Pubitemid 46684648)
21. Ouchi, N. et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 100:2473-2476 (1999). (Pubitemid 30005109)
22. Kobashi, C. et al. Adiponectin inhibits endothelial synthesis of interleukin-8. Circ Res 97:1245-1252 (2005).
23. Andersson, C. X., Gustafson, B., Hammarstedt, A., Hedjazifar, S. & Smith, U. Inflamed adipose tissue, insulin resistance and vascular injury. Diabetes Metab Res Rev 24:595-603 (2008).
24. Yokota, T. et al. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood 96:1723-1732 (2000). (Pubitemid 30661055)
25. Chen, H., Montagnani, M., Funahashi, T., Shimomura, I. & Quon, M. J. Adiponectin stimulates production of nitric oxide in vascular endothelial cells. J Biol Chem 278:45021-45026 (2003). (Pubitemid 37377262)
26. Behre, C. J., Brohall, G., Hulthe, J., Wikstrand, J. & Fagerberg, B. Are serum adiponectin concentrations in a population sample of 64-year-old Caucasian women with varying glucose tolerance associated with ultrasound-assessed atherosclerosis? J Intern Med 260:238-244 (2006). (Pubitemid 44253637)
27. Karakitsos, D. et al. Adiponectin and cardiovascular remodeling in end-stage renal disease and co-morbid diabetes mellitus. Am J Nephrol 26:340-347 (2006). (Pubitemid 44394152)
28. Nishida, M. et al. Effects of IL-6, adiponectin, CRP and metabolic syndrome on subclinical atherosclerosis. Clin Chim Acta 384:99-104 (2007). (Pubitemid 47248651)
29. Nilsson, P. M. et al. Plasma adiponectin levels in relation to carotid intima media thickness and markers of insulin resistance. Arterioscler Thromb Vasc Biol 26: 2758-2762 (2006).
30. Sattar, N. et al. Adiponectin and coronary heart disease: a prospective study and meta-analysis. Circulation 114:623-629 (2006). (Pubitemid 44252303)
31. Dullaart, R. P., Kappelle, P. J. & Dallinga-Thie, G. M. Carotid intima media thickness is associated with plasma adiponectin but not with the leptin:adiponectin ratio independently of metabolic syndrome. Atherosclerosis 211:393-396 (2010).
32. Hara, K. et al. Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome. Diabetes Care 29:1357-1362 (2006). (Pubitemid 44125935)
33. O'Leary, D. H. et al. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 340:14-22 (1999).
34. Bots, M. L., Hoes, A. W., Koudstaal, P. J., Hofman, A. & Grobbee, D. E. Common carotid intima-mediathickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation 96:1432-1437 (1997). (Pubitemid 27375333)